Apogee Therapeutics Files DEF 14A for April 10, 2026 Apogee Therapeutics filed a Form DEF 14A on Apr 10, 2026 (SEC); proxy sets the vote window and will influence ISS/Glass Lewis guidance within 2–6 weeks, affecting investor engagement.

Apogee Therapeutics Files DEF 14A for April 10, 2026: Apogee Therapeutics filed a Form DEF 14A on Apr 10, 2026 (SEC); proxy sets the vote window and will influence ISS/Glass Lewis guidance within 2–6 weeks,… 👈 Read full analysis #ApogeeTherapeutics #DEF14A #SECfiling #InvestorEngagement #ProxyVotes